CCL20-MIP3 alpha is a Novel Anti-HIV-1 Molecule of the Human Female Reproductive Tract

Problem CCL20-MIP3 alpha is a chemokine for immature dendritic cells as well as an antibacterial against gram-positive and gram-negative bacteria. The role of CCL20-MIP3 alpha as an antiviral is unknown. In this study, we have examined the production of CCL20-MIP3 alpha by epithelial cells from the upper female reproductive tract as well as its activity as an antiviral molecule.Method of study Primary uterine and Fallopian tube epithelial cells were treated with Poly(I:C) and CCL20-MIP3 alpha mRNA and protein was measured by Realtime RT-PCR and ELISA assays. Anti-HIV activity was determined using an indicator cell line TZM-bl and quantified by using a luminometer.Results Primary uterine and Fallopian tube epithelial cells produce CCL20-MIP3 alpha constitutively and the production is enhanced following stimulation with viral double-stranded RNA mimic Poly(I:C). Recombinant CCL20-MIP3 alpha was able to inhibit both T-cell-tropic X4-IIIB and macrophage-tropic R5-BaL HIV-1 when virus was directly incubated with CCL20-MIP3 alpha but not when CCL20-MIP3 alpha was added to cells either prior to infection or post-infection. This suggests that the mechanism of inhibition is likely to be a direct interaction between HIV-1 and CCL20-MIP3 alpha .Conclusion This study demonstrates that CCL20-MIP3 alpha is an important endogenous anti-HIV-1 microbicide of the female reproductive tract.